Poland· PL-100142010
Budiair
A budesonide product containing budesonidum, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 15 of 19 countries.
Countries holding a registration under ATC R03BA02 (budesonide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Budesonide · ATC R03BA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Budesonidum
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Poland (PL)
- ATC code
- R03BA02
- ATC class
- Budesonide
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin05909990335176
- gtin059099903351691 poj.po 200 daw.PLN 64.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
686 interactions on record for budesonide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Budesonide · interactions on record
686 records
- 62 severe
- 260 moderate
- 27 minor
- 337 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- Bempedoic acidC10AX15severe
- MifepristoneG03XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Budesonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCortiventOy Leiras Finland Ab
- United KingdomPulmicort 200micrograms/dose inhalerAstraZeneca UK Ltd
- CzechiaBUDIAIRChiesi Pharmaceuticals GmbH, Vídeň
- SpainRIBUJET 200 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESIONChiesi España S.A.U.
- United StatesbudesonideOceanside Pharmaceuticals
- SwedenBudaxiro 3 mg Kapsel med modifierad frisättning, hårdMedical Valley Invest AB
- BelgiumAirbufo Forspiro 160 µg/dose - 4.5 µg/doseSandoz
- NetherlandsBudenofalk 4 mg zetpillenMedcor Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- France · Budésonide Arrow, Budesonide Biogaran
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e9c5f2b-e404-4ce5-a57f-ed3ede9e4dd2 GET /v1/drugs/9e9c5f2b-e404-4ce5-a57f-ed3ede9e4dd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol inhalacyjny, roztwór",
"source": "urpl",
"strength": "200 mcg/dawkę odmierzoną",
"packaging": "05909990335169 ¦ Rp ¦ 27967\n1 pojemnik 200 dawek zaopatrzony w standardowy inhalator z ustnikiem\n05909990335176 ¦ Rp ¦ 27968\n1 pojemnik 200 dawek inhalator z komorą inhalacyjną Jet",
"substance": "Budesonidum 200 mcg",
"common_name": "Budesonidum",
"pl_product_id": "100142010",
"pozwolenie_nr": "11758",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.